Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.78 |
| ▸ | LMNA | P02545 | 1/20 | 0.78 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.78 |
| ▸ | FAAH | O00519 | 3/20 | 0.50 |
| ▸ | TSHR | P16473 | 3/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | ATM | Q13315 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | NAAA | Q02083 | 1/20 | 0.44 |
| ▸ | DGKA | P23743 | 1/20 | 0.44 |
| ▸ | CES2 | O00748 | 2/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | MGAM | O43451 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | SI | P14410 | 1/20 | 0.43 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.43 |
| ▸ | CES1 | P23141 | 1/20 | 0.43 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hexane SCHEMBL10002813 | 1.00 | ALDH1A1 (0.78) | ALDH1A1LMNAHSD17B10FAAHTSHR | |
| Hexane SCHEMBL318366 | 1.00 | ALDH1A1 (0.78) | ALDH1A1LMNAHSD17B10FAAHTSHR | |
| Hexane SCHEMBL15769141 | 1.00 | ALDH1A1 (0.78) | ALDH1A1LMNAHSD17B10FAAHTSHR | |
| Hexane SCHEMBL514605 | 1.00 | ALDH1A1 (0.78) | ALDH1A1LMNAHSD17B10FAAHTSHR | |
| Hexane SCHEMBL57827 | 1.00 | ALDH1A1 (0.78) | ALDH1A1LMNAHSD17B10FAAHTSHR | |
| Hexane SCHEMBL301207 | 1.00 | ALDH1A1 (0.78) | ALDH1A1LMNAHSD17B10FAAHTSHR | |
| Hexane SCHEMBL637278 | 1.00 | ALDH1A1 (0.78) | ALDH1A1LMNAHSD17B10FAAHTSHR | |
| Hexane SCHEMBL4960168 | 1.00 | ALDH1A1 (0.78) | ALDH1A1LMNAHSD17B10FAAHTSHR | |
| Hexane SCHEMBL6720430 | 1.00 | ALDH1A1 (0.78) | ALDH1A1LMNAHSD17B10FAAHTSHR | |
| Hexane SCHEMBL4897173 | 1.00 | ALDH1A1 (0.78) | ALDH1A1LMNAHSD17B10FAAHTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 731 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116283759-A | Preparation method of 2-monofluoromethylquinoline and derivatives thereof | 济南大学 | 2023-06-23 | — | — | CN | claimed |
| EP-1546150-B1 | PYRROLE DERIVATIVES AS INHIBITORS OF CYTEINE PROTEASES | AMURA THERAPEUTICS LTD (GB) | 2009-03-04 | — | — | EP | claimed |
| US-20060100431-A1 | Biologically active compounds | AMURA THERAPEUTICS LIMITED (GB) | 2006-05-11 | — | — | US | claimed |
| EP-4003314-B1 | FUNCTIONALIZED LONG-CHAIN HYDROCARBON MONO- AND DI-CARBOXYLIC ACIDS USEFUL FOR THE PREVENTION OR TREATMENT OF DISEASE | ESPERVITA THERAPEUTICS INC (US) | 2024-07-10 | — | — | EP | disclosed |
| CN-118251379-A | Iron death inhibitor and use thereof | 学校法人自治医科大学 | 2024-06-25 | — | — | CN | disclosed |
| WO-2024126617-A1 | BIFUNCTIONAL COMPOUNDS FOR DEGRADING KINASES VIA UBIQUITIN PROTEOSOME PATHWAY | CROSSFIRE ONCOLOGY HOLDING B.V. (NL) | 2024-06-20 | — | — | WO | disclosed |
| CN-118176179-A | Novel spiro compounds | 田边三菱制药株式会社 | 2024-06-11 | — | — | CN | disclosed |
| CN-117865977-A | Organic compound, composition containing same and organic electroluminescent device | 石家庄诚志永华显示材料有限公司 | 2024-04-12 | — | — | CN | disclosed |
| WO-2024075825-A1 | CYCLOPENTANE COMPOUND | キッセイ薬品工業株式会社 | 2024-04-11 | — | — | WO | disclosed |
| US-20240116943-A1 | TETRAHYDROBENZOFURODIAZEPINONE COMPOUND AND PHARMACEUTICAL USE THEREOF | JAPAN TOBACCO INC. (JP) | 2024-04-11 | — | — | US | disclosed |
| US-20240108607-A1 | METHOD FOR MANUFACTURING NOVEL NITROGEN-CONTAINING COMPOUND OR SALT THEREOF AND MANUFACTURING INTERMEDIATE OF NOVEL NITROGEN-CONTAINING COMPOUND OR SALT THEREOF | FUJIFILM CORPORATION (JP) | 2024-04-04 | — | — | US | disclosed |
| EP-0148953-B1 | 7-FLUOROPROSTAGLANDINS AND PROCESS FOR THEIR PREPARATION | ASAHI GLASS COMPANY LTD. (JP) | 1990-09-26 | — | — | EP | disclosed |
| WO-1990009981-A1 | PREPARATION OF OPTICALLY ACTIVE GLYCEROL DERIVATIVES | ISIS INNOVATION LIMITED (GB) | 1990-09-07 | — | — | WO | disclosed |
| US-4952710-A | STARTING MATERIAL FOR OPTICALLY ACTIVE PROSTAGLANDINS | G. D. SEARLE & CO. (US) | 1990-08-28 | — | — | US | disclosed |
| EP-0362816-A1 | Cyclopenteneheptanoic acid derivatives and method of preparation thereof | G.D. Searle & Co. (US) | 1990-04-11 | — | — | EP | disclosed |
| EP-0360324-A1 | Tricyclic aromatase inhibitors | AKZO N.V. (NL) | 1990-03-28 | — | — | EP | disclosed |
| US-4900725-A | CONTRACEPTIVES | ROUSSEL UCLAF (FR) | 1990-02-13 | — | — | US | disclosed |
| US-4822909-A | 7-fluoroprostaglandins and process for their production | ASASHI GLASS COMPANY LTD. (JP) | 1989-04-18 | — | — | US | disclosed |
| US-4699989-A | 7-fluoroprostaglandins and process for their production | ASAHI GLASS COMPANY LTD. (JP) | 1987-10-13 | — | — | US | disclosed |
| EP-0148953-A1 | 7-FLUOROPROSTAGLANDINS AND PROCESS FOR THEIR PREPARATION | ASAHI GLASS COMPANY LTD. (JP) | 1985-07-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240116943-A1 | TETRAHYDROBENZOFURODIAZEPINONE COMPOUND AND PHARMACEUTICAL USE THEREOF | PIM1, PIM2, PIM3 | ALDH1A1 76/4885LMNA 3718/4885HSD17B10 906/4885 |
| US-20060100431-A1 | Biologically active compounds | SOST, CTSK, CTSS | ALDH1A1 4151/4885LMNA 3686/4885HSD17B10 1043/4885 |
| US-20240108607-A1 | METHOD FOR MANUFACTURING NOVEL NITROGEN-CONTAINING COMPOUND OR SALT THEREOF AND MANUFACTURING INTERMEDIATE OF NOVEL NITROGEN-CONTAINING COMPOUND OR SALT THEREOF | C9, C5, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 | ALDH1A1 3243/4885LMNA 1121/4885HSD17B10 2495/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.